课题基金 / 基金详情

注射可能な吸収性ゲルのドラッグデリバリーシステムの開発-低侵襲の新規骨造成法

注射可能な吸収性ゲルのドラッグデリバリーシステムの開発-低侵襲の新規骨造成法
可注射可吸收凝胶给药系统的开发——一种新型微创骨移植方法
批准号:
26932001
负责人:
ハオ 佳
金额:
$0.38万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Encouragement of Scientists
财政年份:
2014
资助国家:
日本
项目状态:
已结题
起止时间:
2014-04-01 至 2015-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
OBJECTIVES : To achieve ideal functional and aesthetic requirements, ridge augmentation is often required before dental implant placement. Bone augmentation (especially vertical), which normally consists of complex and invasive surgeries, still remains challenge. This study seeks to investigate the feasibility of an injectable in situ gel-forming system containing strontium hydroxyapatite (SrHA) and alginate (Alg) and also evaluate the addition of simvastatin (SIM) in the SrHA-Alg system as a stimulant to further enhance bone formation in the minimally invasive manner.MATERIAL AND METHODS : SrHA-Alg-SIM solution was prepared with low, medium and high doses of SIM according to the previous protocol, and each animal received a 200-μL single subperiosteal injection of either SrHA-Alg-SIM solution or SrHA-Alg solution alone as control. The new bone formation was assessed at 0, 4, and 8 weeks histologically and radiologically.RESULTS : The SrHA-alginate solution materials could form solid gel once injected. As such, no sutures were required to close the injection site. Significantly greater amount of new bone formation was observed in the SrHA-Alg-SIM (Low dose) group compared with the other groups both by micro-CT and by histological section.CONCLUSIONS : Rat calvarial bone augmentation was achieved by a single subperiosteal injection of SrHA-Alg-SIM solution without any administration of stem cells or growth factors. The low dose of simvastatin incorporated seemed to have the best stimulatory effect in bone formation. The in situ gel-forming material may hold potential therapeutic benefits for local bone augmentation in a minimally invasive manner.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
海外基金